Over the following 6 to 8 days, the concentration gradually declines as your body metabolizes the compound, primarily through hepatic pathways that do not interact with cytochrome P450 enzymes
In December 2024 , the FDA determined that AOD-9604 (both free base and acetate forms) should not be included on the 503A Bulks List for pharmaceutical compounding, citing concerns over limited long-term safety data, peptide impurities, and potential immunogenicity
BPC-157 Spray (5mg Per Bottle) $39.99 $99.99Price range: $39.99 through $99.99 Product Overview BPC-157 Spray (RUO) is formulated exclusively for research and laboratory use
Available: [22] J
however, this is FDA staff's proposed position going into the meeting, not a final action, and the committee's discussion, any vote, and FDA's ultimate decision are still pending, so the outcome of the review is not yet known